What Analysts Have to Say About Celldex Therapeutics (CLDX)?

The results of the trading session contributed to over 2,138,609 shares changing hands.

All these opinions have come together to present the composite price target for the stock. As of the end of the quarter Vident Investment Advisory, LLC had acquired a total of 243,963 shares growing its stake by 103.4%. Along with these its last twelve month performance is stands at -42.61% while moved -33.27% for the past six months.

Celldex Therapeutics, maintained at an average outperform rating by 6 stock analysts, and there are at least 5.63% of shares outstanding that are now legally short sold.

Celldex Therapeutics Incorporated (NASDAQ:CLDX) had an increase of 1.26% in short interest. The North Run Capital Lp holds 2.37M shares with $3.27 million value, down from 3.14 million last quarter. Celldex Therapeutics, Inc. (NASDAQ:CLDX) has declined 20.62% since October 24, 2016 and is downtrending. Finally, Bank of New York Mellon Corp grew its stake in shares of Celldex Therapeutics by 1.1% in the first quarter.

While considering EPS estimates of the company, it has next quarter growth estimates of 0.21 whereas during current year it has 0.56 estimations over growth, comparing to the estimations of 0.58 during next year.

Among 12 analysts covering Celldex Therapeutics (NASDAQ:CLDX), 7 have Buy rating, 0 Sell and 5 Hold. The company's distance from 52-week high price is -14.55% and while current price is 22.37% from 52-week low price. The stock closing price is now trading downward to its 50 day moving average with change of -20.38%, tumbled to its 20 day moving average with figure of -5.09% and behind its 200 day moving average with value -66.14%. The company has market cap of $337.54 million. (NASDAQ:CLDX) have caught the attention of investors. The biopharmaceutical company reported ($0.23) EPS for the quarter, beating the Zacks' consensus estimate of ($0.28) by $0.05. That compares with the recent volume average of 0.45 million. The company now has a Return on Equity of -51.9% and a Return on Investment of -50.1%. The company's quarterly revenue was up 175.5% compared to the same quarter a year ago. At one point in the past year, the shares traded as low as $0.40 but has recovered 52.9% since then.

The price target set for the Celldex Therapeutics, Inc.

CLDX has been the topic of several recent analyst reports. (NASDAQ:CLDX) on Tuesday, August 11 with "Outperform" rating.

Investigating the productivity proportions of TherapeuticsMD, Inc., (NASDAQ: TXMD) stock, speculator will discover its ROE, ROA, ROI remaining at -74.2%, -66.6% and 15.8%, individually. HC Wainwright set a $10.00 price objective on shares of Celldex Therapeutics and gave the company a "buy" rating in a report on Wednesday, August 9th. In this case performance of tends to percentage rate of return for a stock for a given time frame. The rating was downgraded by Leerink Swann to "Market Perform" on Monday, March 7. Using the CCI as a leading indicator, technical analysts may use a +100 reading as an overbought signal and a -100 reading as an oversold indicator, suggesting a trend reversal. The rating was maintained by Jefferies with "Hold" on Monday, June 12. If you are accessing this story on another domain, it was stolen and reposted in violation of U.S. and worldwide trademark & copyright laws. Below is a list of Celldex Therapeutics, Inc.

Like this



26 October 2017
Lexus LC Inspiration Series and Black Panther concept revealed
This vehicle's most alluring feature is its Structural Blue paint job inspired by iridescent morpho butterflies. The Black Panther-inspired LC concept coupe boasts a variety of features that every Marvel hero needs.

26 October 2017
Revenue Estimates for Investors: Cognizant Technology Solutions Corporation (CTSH)
Recent trading patterns in the stock of Cognizant Technology Solutions Corporation (NASDAQ: CTSH ) have investors on high alert. Moreover, Capital Advisers Ltd Com has 0.1% invested in Cognizant Technology Solutions Corp (NASDAQ: CTSH ) for 175,794 shares.

26 October 2017
Guatemalan first to be convicted in US FIFA inquiry
Federation Internationale de Football Association has conducted internal investigations of corruption and self-dealing. The former secretary-general of the football federation of Guatemala Hector Trujillo to NY , on October 25, 2017.

26 October 2017
The Latest Colgate-Palmolive Company (CL) Insider Trading Activity
The bid price was Rs.1046.20 for 21 stocks while the ask price was Rs.1046.90 for 16 stocks making the bid-ask spread to be -0.7. The stock of Colgate-Palmolive Company (NYSE:CL) has "Overweight" rating given on Wednesday, January 6 by Atlantic Securities.

26 October 2017
Dominant Pakistan to face Sri Lanka in 1st T20I today
The first T20I will be played on Thursday, but all eyes will be on the third match at Lahore. But I wasn't frightened after informing; in fact, I was more scared watching myself on TV.

26 October 2017
Ne-Yo & Wife Crystal Announce Second Pregnancy
However, despite that fact, Shaw explained her primary obligation is to make sure her kids get along well and, more importantly, she gets along with her ex-husband and his new wife.

26 October 2017
SC to hear UP govt on Taj Mahal parking October 27
The CM also sanctioned Rs 370 crore on the behalf of the state government for the development of Agra and promotion of tourism. The Uttar Pradesh government's plea was taken up on Monday, with the court asking the state to file an affidavit by Tuesday.

26 October 2017
Breast Cancer in Men Diagnosed Late due to Low Awareness
The report uncovered a number of issues that need to be addressed in the prevention, diagnosis and treatment of breast cancer . During the self-examination, men must carefully observe their chest and look for any distortion or lumps.

26 October 2017
Mega Millions ticket costs - and jackpots - set to increase
Starting jackpots will more than double - from $15 million up to $40 million and the jackpots will grow faster as well. The cost of a Mega Millions ticket will rise to $2 beginning Saturday.

26 October 2017
Bisping sued for allegedly assaulting teen at gym
Bisping has not fought since a year ago but is set to take on Georges St-Pierre in Madison Square Garden on November 4. But, of course, Bisping's promised that things will be different when they battle on November 4th.